Global Pharmaceutical Intelligence

Smarter Sourcing, Faster Drug Launches, Quicker Business Leads, Killer Sales

A large pharmaceutical company in the Middle East is looking for partners to in-license biosimilar products to market them in the MENA region. The business development team will be attending CPhI Worldwide in Frankfurt and would be interested in meeting potential suppliers interested in this opportunity.

A marketing and distribution company based in Lithuania with more than 50% market share of the oncology market in the country is searching for the following products:
1. Carboplatin 150 mg N1 9000 Units/year
2. Calcium folinate 100 mg/10 ml N1 24000 Units/year
3. Docetaxel 10 mg/ml 2 ml N1 6300 Units/year
4. Docetaxel 10 mg/ml 8 ml N1 1500 Units/year
5. Doxorubicin 50 mg/25 ml N1 2 mg/ml 25 ml N1 4000 Units/year
6. Doxorubicin 10 mg/5 ml N1 2 mg/ml 5 ml N1 5000 Units/year
7. Etoposide 100 mg/5 ml N1 20 mg/ml amp. 5ml N1 13000 Units/year
8. Fluorouracil 50 mg/ ml 5 ml (250 mg) 10000 Units/year
9. Fluorouracil 50 mg/ ml 10 ml (500 mg) 20000 Units/year
10. Paclitaxel 6 mg/ ml 30 mg N1 14500 Units/year
Interested companies/partners are requested to share their contact details to schedule a meet at CPhI Europe.

A Top 5 Global Pharmaceutical Company is looking for regulatory organizations offering contract services to perform registrations, post-approval lifecycle management etc. activities in the Eastern Europe, Middle East & Africa (EEMEA) regions. The Business Development Director leading this project will be attending CPhI Worldwide in Frankfurt and is interested in connecting with organizations that have an established presence in these markets.